Pharmaceutical Companies Rush To Patent Medical Marijuana —By TruthOnPot.Com

«As crazy as it sounds, the only difference between a £175 bottle of Sativex and a $20 bottle of marijuana extract from your local dispensary are the patents that GW Pharma has been all-too-quick to file.

Just last month, GW Pharma’s newest patent application was published with the title “Phytocannabinoids in the treatment of cancer.” […]

[P]harmaceutical companies are well aware of the loopholes in patent laws that can easily be exploited by slightly altering a chemical or formula, which is what seems to be the case with GW Pharma. In their most recent patent, all GW Pharma had to do to claim exclusive rights to the cancer-fighting effects of cannabis was to call it a “botanical drug substance”, which they define as a mixture of cannabinoids and non-cannabinoid materials.»